了解RhoB如何调节NSCLC中Akt抑制效率的进展
Nurullah Akgun1, Zekai Halici1, Elif Cadirci1
1Department of Pharmacology, Faculty of Medicine, Ataturk University, 25240, Erzurum, Turkey.
Current cancer drug targets
|January 17, 2025
概括
在非小细胞肺癌 (NSCLC) 中,RhoB负面调节了Akt抑制的抗瘤作用. 沉默RhoB增强了Akt抑制剂的疗效,增加了细胞亡并减少了NSCLC细胞的增殖.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 阿克特抑制是肺癌治疗的一个有前途的策略.
- 了解调节机制对于提高Akt抑制剂的有效性至关重要.
研究的目的:
- 研究RhoB在调节非小细胞肺癌 (NSCLC) 中Akt抑制中的作用.
- 为了确定RhoB是否调节NSCLC中的Akt抑制剂的抗瘤活性.
主要方法:
- 使用了A549 NSCLC细胞系.
- 使用小干扰RNA (siRNA) 进行RhoB敲击.
- 用 перифозин (Akt 抑制剂) 治疗的细胞和评估的增殖,pAkt 水平和亡.
主要成果:
- 升调RhoB降低了阿克特抑制剂的抗增殖活性.
- 当与Akt抑制相结合时,RhoB沉默显著降低了pAkt水平并增加了细胞亡率.
- 在NSCLC细胞中,RhoB作为Akt抑制剂功效的负调节剂.
结论:
- 已确定RhoB是Akt抑制NSCLC中抗瘤活性的负调节剂.
- RhoB表达水平可能是预测对Akt抑制疗法的反应的关键因素.
- 准RhoB可能为NSCLC治疗提供新的治疗策略.
更多相关视频
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.0K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.8K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
